Literature DB >> 21209164

Detection of Klebsiella pneumoniae carbapenemase (KPC) production in non-Klebsiella pneumoniae Enterobacteriaceae isolates by use of the Phoenix, Vitek 2, and disk diffusion methods.

Christopher D Doern1, W Michael Dunne, Carey-Ann D Burnham.   

Abstract

In this study, we tested the abilities of the Vitek 2, BD Phoenix, and Kirby Bauer disk diffusion tests to detect carbapenemase production in a collection of 14 Klebsiella pneumoniae carbapenemase (KPC)-producing non-Klebsiella pneumoniae isolates. In addition, we evaluated 13 KPC-positive K. pneumoniae isolates by using each of these methods and applied both 2009 and 2010 CLSI carbapenem interpretive guidelines.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21209164      PMCID： PMC3067756          DOI： 10.1128/JCM.02163-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  Comparison of disk diffusion, Etest and VITEK2 for detection of carbapenemase-producing Klebsiella pneumoniae with the EUCAST and CLSI breakpoint systems.

Authors:  M Vading; Ø Samuelsen; B Haldorsen; A S Sundsfjord; C G Giske
Journal:  Clin Microbiol Infect       Date:  2011-05       Impact factor: 8.067

2.  Performance of the Phoenix bacterial identification system compared with disc diffusion methods for identifying extended-spectrum beta-lactamase, AmpC and KPC producers.

Authors:  Mark A Fisher; Paul D Stamper; Kristine M Hujer; Zachary Love; Ann Croft; Samuel Cohen; Robert A Bonomo; Karen C Carroll; Cathy A Petti
Journal:  J Med Microbiol       Date:  2009-06       Impact factor: 2.472

3.  Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results.

Authors:  Cecilia G Carvalhaes; Renata C Picão; Adriana G Nicoletti; Danilo E Xavier; Ana C Gales
Journal:  J Antimicrob Chemother       Date:  2009-12-08       Impact factor: 5.790

4.  Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.

Authors:  H Yigit; A M Queenan; G J Anderson; A Domenech-Sanchez; J W Biddle; C D Steward; S Alberti; K Bush; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

5.  Evaluation of boronic acid disk tests for differentiating KPC-possessing Klebsiella pneumoniae isolates in the clinical laboratory.

Authors:  Athanassios Tsakris; Ioulia Kristo; Aggeliki Poulou; Katerina Themeli-Digalaki; Alexandros Ikonomidis; Dimitra Petropoulou; Spyros Pournaras; Danai Sofianou
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

6.  Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06.

Authors:  David M Livermore; Russell Hope; Geraldine Brick; Mark Lillie; Rosy Reynolds
Journal:  J Antimicrob Chemother       Date:  2008-11       Impact factor: 5.790

7.  Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem.

Authors:  Scott A Weisenberg; Daniel J Morgan; Rosanny Espinal-Witter; Davise H Larone
Journal:  Diagn Microbiol Infect Dis       Date:  2009-04-02       Impact factor: 2.803

8.  Detection of KPC-2 in a clinical isolate of Proteus mirabilis and first reported description of carbapenemase resistance caused by a KPC beta-lactamase in P. mirabilis.

Authors:  R Tibbetts; J G Frye; J Marschall; D Warren; W Dunne
Journal:  J Clin Microbiol       Date:  2008-07-16       Impact factor: 5.948

9.  Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes.

Authors:  Dror Marchaim; Shiri Navon-Venezia; Mitchell J Schwaber; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2008-01-28       Impact factor: 5.191

10.  Use of boronic acid disk tests to detect extended- spectrum beta-lactamases in clinical isolates of KPC carbapenemase-possessing enterobacteriaceae.

Authors:  Athanassios Tsakris; Aggeliki Poulou; Katerina Themeli-Digalaki; Evangelia Voulgari; Theodore Pittaras; Danai Sofianou; Spyros Pournaras; Dimitra Petropoulou
Journal:  J Clin Microbiol       Date:  2009-09-02       Impact factor: 5.948
View more
  21 in total

1.  Comparative evaluation of combined-disk tests using different boronic acid compounds for detection of klebsiella pneumoniae carbapenemase-producing enterobacteriaceae clinical isolates.

Authors:  Athanassios Tsakris; Katerina Themeli-Digalaki; Aggeliki Poulou; Georgia Vrioni; Evangelia Voulgari; Vasiliki Koumaki; Antonella Agodi; Spyros Pournaras; Danai Sofianou
Journal:  J Clin Microbiol       Date:  2011-06-01       Impact factor: 5.948

Review 2.  Intestinal Carriage of Carbapenemase-Producing Organisms: Current Status of Surveillance Methods.

Authors:  Roberto Viau; Karen M Frank; Michael R Jacobs; Brigid Wilson; Keith Kaye; Curtis J Donskey; Federico Perez; Andrea Endimiani; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

3.  First Canadian outbreak of Enterobacteriaceae-expressing Klebsiella pneumoniae carbapenemase type 3.

Authors:  Victor Leung; Vivian G Loo; Charles Frenette; Marc-Christian Domingo; Anne-Marie Bourgault; Michael R Mulvey; Hugh G Robson
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

4.  Detection of colonization by carbapenemase-producing Gram-negative Bacilli in patients by use of the Xpert MDRO assay.

Authors:  Fred C Tenover; Rafael Canton; JoAnn Kop; Ryan Chan; Jamie Ryan; Fred Weir; Patricia Ruiz-Garbajosa; Vincent LaBombardi; David H Persing
Journal:  J Clin Microbiol       Date:  2013-09-04       Impact factor: 5.948

5.  Evaluation of phenotypic detection methods for metallo-β-lactamases (MBLs) in clinical isolates of Pseudomonas aeruginosa.

Authors:  S Peter; A Lacher; M Marschal; F Hölzl; M Buhl; I Autenrieth; M Kaase; M Willmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-23       Impact factor: 3.267

6.  Accuracy of carbapenem nonsusceptibility for identification of KPC-possessing Enterobacteriaceae by use of the revised CLSI breakpoints.

Authors:  David Landman; Julius Salamera; Manisha Singh; John Quale
Journal:  J Clin Microbiol       Date:  2011-08-31       Impact factor: 5.948

7.  Comparison of chromogenic media for recovery of carbapenemase-producing enterobacteriaceae (CPE) and evaluation of CPE prevalence at a tertiary care academic medical center.

Authors:  Morgan A Pence; Tiffany Hink; Carey-Ann D Burnham
Journal:  J Clin Microbiol       Date:  2014-11-19       Impact factor: 5.948

8.  Use of faropenem as an indicator of carbapenemase activity in the Enterobacteriaceae.

Authors:  Kathryn M Day; Rachel Pike; Trevor G Winstanley; Clare Lanyon; Stephen P Cummings; Muhammad W Raza; Neil Woodford; John D Perry
Journal:  J Clin Microbiol       Date:  2013-04-10       Impact factor: 5.948

Review 9.  Impact of 21st Century Cures Act on Breakpoints and Commercial Antimicrobial Susceptibility Test Systems: Progress and Pitfalls.

Authors:  Romney M Humphries; Mary Jane Ferraro; Janet A Hindler
Journal:  J Clin Microbiol       Date:  2018-04-25       Impact factor: 5.948

10.  Carbapenem-Resistant Enterobacteriaceae Infections in Children.

Authors:  Kathleen Chiotos; Jennifer H Han; Pranita D Tamma
Journal:  Curr Infect Dis Rep       Date:  2016-01       Impact factor: 3.725
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.